N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142131 |
| CAS No | NA |
| Mol.F. | C15H13N3O7 |
| Mol.Wt. | 347.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142132 |
| CAS No | NA |
| Mol.F. | C13H11N3O7S |
| Mol.Wt. | 353.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142133 |
| CAS No | NA |
| Mol.F. | C31H32ClFN8O3 |
| Mol.Wt. | 619.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142134 |
| CAS No | NA |
| Mol.F. | C29H33ClN8O2 |
| Mol.Wt. | 561.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142135 |
| CAS No | NA |
| Mol.F. | C30H40N8O4 |
| Mol.Wt. | 576.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142136 |
| CAS No | NA |
| Mol.F. | C24H36N8O4 |
| Mol.Wt. | 500.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142137 |
| CAS No | NA |
| Mol.F. | C19H28N8O2 |
| Mol.Wt. | 400.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142138 |
| CAS No | NA |
| Mol.F. | C6H9N5O2 |
| Mol.Wt. | 183.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142139 |
| CAS No | NA |
| Mol.F. | C26H34N8O2 |
| Mol.Wt. | 490.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142140 |
| CAS No | NA |
| Mol.F. | C19H28N8O2 |
| Mol.Wt. | 400.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142141 |
| CAS No | NA |
| Mol.F. | C6H10N4O |
| Mol.Wt. | 154.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142142 |
| CAS No | 58246-54-1 |
| Mol.F. | C5H10N2O2 |
| Mol.Wt. | 130.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142143 |
| CAS No | NA |
| Mol.F. | C18H25N9O3 |
| Mol.Wt. | 415.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142144 |
| CAS No | NA |
| Mol.F. | C18H24N10O4 |
| Mol.Wt. | 444.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142145 |
| CAS No | NA |
| Mol.F. | C20H22ClN7O |
| Mol.Wt. | 411.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142146 |
| CAS No | NA |
| Mol.F. | C28H30ClN9O3 |
| Mol.Wt. | 576.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |